| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_970f88705237c21ccb632ac72b17ffc9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-28 |
| filingDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9965b41580132ccd72d2522f0bab8d64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c402d32767612dab28b3b96a7bbf83a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_948a7327713c545c971f15b9705eefab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c4deb577306a11f4c1422c71f212eac |
| publicationDate |
2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013067639-A |
| titleOfInvention |
Method of treating prostate disease based on local delivery of active substance |
| abstract |
A novel method for the treatment of prostate-related diseases that leads to a more effective therapy, while at the same time reducing the need for therapy and radiofrequency treatment and minimizing hormone-related side effects. Provided. I) optionally administering an initial increasing dose of one or more active agents and / or prodrugs to a subject; and ii) a controlled release comprising one or more active agents in a biodegradable ceramic carrier. A method for treating a prostate-related disease in a patient, comprising locally administering the sex pharmaceutical composition into the prostate. The biodegradable hydratable ceramic can be selected from the group consisting of biodegradable ceramic carriers such as non-hydrated or hydrated calcium sulfate. [Selection figure] None |
| priorityDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |